Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Vaccines(2024)
Key words
COVID-19,neutralizing antibodies,anti-RBD antibodies,vaccine effectiveness,study longitudinal,ChAdOx1-S,BNT162b2,CoronaVac,dose booster
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined